Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.28

€0.28

-
-
-
€0.000
 
16.06.23 / Tradegate WKN: A1W8DY / Symbol: SRNE / Name: Sorrento / Stock / Biotechnology & Medical Research / Small Cap / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Sorrento Therapeutics Inc. Stock

With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Sorrento Therapeutics Inc. stock is not clear.
So far the community has only identified positive things for Sorrento Therapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Sorrento Therapeutics Inc. in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Sorrento Therapeutics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Sorrento Therapeutics Inc. - - - - - - -
Evolus Inc 1.160% -3.488% -9.290% 4.403% 17.730% 131.391% -
Brainstorm Cell -2.630% -54.433% -88.438% -95.916% -86.953% -98.588% -
Atara Biotherapeutics Inc. -2.750% -6.965% -0.520% -62.836% -51.634% -87.010% -

Comments

Buy Sorrento Therapeutics Inc.
Show more

Sell Sorrento Therapeutics Inc.
Show more

Buy Sorrento Therapeutics Inc.
Show more

News

Why Shares of Scilex Are Dropping Monday: https://g.foolcdn.com/editorial/images/748024/2valuestocks.jpg
Why Shares of Scilex Are Dropping Monday

Shares of Scilex (NASDAQ: SCLX) were down more than 14% as of 1 p.m. ET on Monday, despite the company announcing positive phase 2 trial results for its non-opioid pain therapy SP-103. The healthcar